AzTrials
AzTrials

Mild Cognitive ImpairmentGAPNCT06403345

A Feasiblity Study of Green Activity Program for People Living With Memory Challenges

A study testing Green Activity Program in people with Mild Cognitive Impairment and Alzheimer Disease, run by Indiana University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this study is to test the Green Activity Program that was designed with people living with memory challenges and their study partners to see if it can be done and if they enjoy the program. "Green activities" are nature activities that the person enjoys and can be done with other people or pets. Read more about this study

Who is it for?
Ages 45 years and older
What is being tested?
Green Activity Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteUnited States
Study dates
17 Jul 2024to 30 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 45 years or older
  • Has memory challenges or difficulties thinking
  • Have access and ability to respond to the telephone (mobile or landline)
  • Study partner
  • 18 years or older
  • Speaks Spanish or English
Show all 10Show fewer
  • Identified by the PLMC as a person they feel comfortable with who they would like to join them in the study. The study partner's participation is based on level of support needed for the PLMC.
  • Outdoor activity professionals
  • 18 years or older
  • at least 1 year experience providing outdoor activities

Who cannot join

  • Participants living with memory challenges will be excluded if they do not meet inclusion criteria or if they indicate any of the following on the 2023 Physical Activity Readiness Questionnaire + (PAR-Q+) :
  • Heart failure or, difficulty controlling Coronary Artery Disease, Diagnosed Abnormality of Heart Rhythm, or other cardiovascular condition.
  • If they report difficulty controlling CAD, Diagnosed abnormality of heart rhythm they will be excluded.
  • If they endorse a diagnosis of heart failure, AND report symptoms greater than NYHA Functional Classification Stage I: "No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation or shortness of breath," they will be excluded. Research assistants will be trained to ask about these symptoms during usual activities of daily living.
  • If their doctor has told them not to participate in physical activity due to their heart condition or another medical condition, they will be excluded.
  • Cancer and are in an active cycle of infusion chemotherapy or daily radiation treatments.
Show all 11Show fewer
  • People with cancer whose treatment regimen does not impact their day to day routines (e.g.-oral chemotherapy agents) may participate. Research assistants will be trained to ask about the impact of cancer and cancer care on day to day activities and physical activity.
  • If their doctor has told them not to participate in physical activity due to their cancer or cancer treatment or another medical condition, they will be excluded.
  • Experienced a black out, fainted, or lost consciousness as a result of a head injury in the past 12 months.
  • Often experienced signs and symptoms of low blood sugar (hypoglycemia) following exercise and/or daily activities.
  • 2 or more hospitalizations in 6 months

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Rebecca Lassell, PhD contact

812-855-2395

blassell@iu.edu

Triana Pena contact

tripena@iu.edu

United States1 site, 1 recruiting
  • Indiana University Bloomington

    Bloomington, Indiana, 47401

    Rebecca Lassell, PhD

    Recruiting

Other trials in United States

About this study

The purpose of this study is to test the Green Activity Program that was designed with people living with memory challenges and their study partners to see if it can be done and if they enjoy the program. "Green activities" are nature activities that the person enjoys and can be done with other people or pets. For example, dog walking, hiking, outdoor yoga, and gardening are all green activities. The purpose of the program is to help people living with memory challenges participate in nature activities they enjoy. The goal of the program is to help people stay active and improve their health and well-being.

Read the detailed description

This is a single arm pre/post feasibility study lasting up to 1 year. Investigators will recruit in n=40 dyads (people living with memory challenges and their study partners n=80 total) and expect n=30 (n=60 total people living with memory challenges and study partners) to complete the 12-week GAP and evaluate it for feasibility and acceptability. Anonymous program evaluation surveys will be administered either via paper or RedCap survey to the outdoor activity professionals who participated in the study. Brief recorded phone interviews (5 minutes) will be conducted with the people living with memory challenges and their study partners after the intervention and 15-minute brief calls with the outdoor activity professionals will be used to gather feedback to refine the program. Informal conversations with the occupational therapist(s) delivering the intervention will occur to identify areas for refinement and will be documented with anonymous notes and no identifiable data collected from them. Sustained behavior change will be measured in people living with memory challenges at 4 weeks after the intervention.

Being tested
Green Activity Program
Medical subject headings
Cognitive Dysfunction, Alzheimer Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Green Activity ProgramBehavioural

    See arm description.

Study groups in NCT06403345
Study groupRoleWhat they receive
Single arm pre/post studyExperimentalGAP 12-week Intervention for People Living with Memory Loss \& Study Partners involves an evaluation, goal-setting, coaching and strategy training over 4-8 virtual or phone sessions for 30-90 minutes each over 12 weeks, with 2 phone or virtual check-ins for 15-30 minutes. GAP Intervention Outdoor Activity Professionals involves a site-evaluation (Accessibility, Fall risk) and education on Dementia Training, SMART Goal setting, Strategy Training for Tailoring Nature Activities, and Behavioral Activation strategies with support from the OT.
Receives: Behavioral: Green Activity Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility intervention completion rate

    intervention completion rate of 75%

    Measured: Through study completion

  2. Other Feasibility measures

    75% attendance, 75% retention, intervention fidelity using a checklist by an outside rater with at least 75% of potential active ingredients present in 25% of randomly sampled sessions: tailoring (environment, activity, personalized delivery), behavioral activation, and nature (outdoor environment or incorporating nature [plant or animal]). Feasibility data of recruitment rates (eligible participants/# recruited per month), feasibility of assessments (time to complete, with an 80% completion rate) will be collected, and we will also track missing data.

    Measured: Through study completion

  3. Acceptability

    Two selected questions from the Intervention Tolerability scale will be asked to the person living with memory challenges over the phone: "The program was easy to use" and "I liked this program." Rated by (yes/no). We expect at least 70% of people living with memory challenges will be satisfied with the intervention (yes to both questions).

    Measured: Up to one month after the 12-week program.

Secondary outcomes (28)
  1. Goal Attainment Scaling

    Primary goal met (yes/no)

    Measured: Up to one month after the 12-week program

  2. Quick Physical Activity Scale

    Physical activity

    Measured: Up to 1 month before and after the 12-week program

  3. Heart Rate

    ActiGraph LEAP

    Measured: 1 week pre 12-week program and 1 week post

  4. Physical activity

    ActiGraph LEAP

    Measured: 1 week pre 12-week program and 1 week post

  5. Sedentary time

    ActiGraph LEAP

    Measured: 1 week pre 12-week program and 1 week post

  6. Health

    Patient-Reported Outcomes Measurement Information System: Physical health. Scored on the T-score metric. High scores mean more of the concept being measured.

    A score of 40 is one SD lower than the mean of the reference population. A score of 60 is one SD higher than the mean of the reference population.

    Measured: Up to 1 month before and after the 12-week program

  7. Well-being

    Patient-Reported Outcomes Measurement Information System: Mental Health. Scored on the T-score metric. High scores mean more of the concept being measured.

    A score of 40 is one SD lower than the mean of the reference population. A score of 60 is one SD higher than the mean of the reference population.

    Measured: Up to 1 month before and after the 12-week program

  8. Social Participation

    Patient-Reported Outcomes Measurement Information System: Satisfaction with participation in social activities. Scored on the T-score metric. High scores mean more of the concept being measured.

    A score of 40 is one SD lower than the mean of the reference population. A score of 60 is one SD higher than the mean of the reference population.

    Measured: Up to 1 month before and after the 12-week program

  9. Depression

    Geriatric Depression Scale short form,

    Measured: Up to 1 month before and after the 12-week program

  10. Behavioral Activation

    Behavioral Activation Scale Short Form

    Measured: Up to 1 month before and after the 12-week program

  11. Sleep

    ActiGraph LEAP

    Measured: 1 week before and 1 week after the 12 week intervention

  12. UCLA 3-item Loneliness scale

    Loneliness

    Measured: Up to 1 month before and after the 12-week program

  13. Neuropsychiatric symptoms

    Neuropsychiatric symptoms questionnaire

    Measured: Up to 1 month before and after the 12-week program

  14. Brief phone interviews

    2 -Post questions over the phone: "What did you like about the program? What would you change?"

    Measured: Up to 1 month after the 12-week program

  15. Study Partner Health

    Patient-Reported Outcomes Measurement Information System: Physical health. Scored on the T-score metric. High scores mean more of the concept being measured.

    A score of 40 is one SD lower than the mean of the reference population. A score of 60 is one SD higher than the mean of the reference population.

    Measured: Up to 1 month before and after the 12-week program

  16. Study Partner well-being

    Patient-Reported Outcomes Measurement Information System: Mental Health. Scored on the T-score metric. High scores mean more of the concept being measured.

    A score of 40 is one SD lower than the mean of the reference population. A score of 60 is one SD higher than the mean of the reference population.

    Measured: Up to 1 month before and after the 12-week program

  17. Study Partner Social Participation

    Patient-Reported Outcomes Measurement Information System: Satisfaction with participation in social activities. Scored on the T-score metric. High scores mean more of the concept being measured.

    A score of 40 is one SD lower than the mean of the reference population. A score of 60 is one SD higher than the mean of the reference population.

    Measured: Up to 1 month before and after the 12-week program

  18. Study Partner Depression

    Geriatric Depression Scale short form

    Measured: Up to 1 month before and after the 12-week program

  19. Feasibility for Study partner

    Feasibility of an Intervention Measure

    Measured: Up to 1 month after the 12-week program

  20. Acceptability for Study Partner

    Acceptability of an Intervention Measure

    Measured: Up to 1 month after the program

  21. Appropriateness for Study Partner

    Appropriateness of an Intervention Measure

    Measured: Up to 1 month after the 12-week program

  22. Brief phone interview

    "What did you like about the program? What would you change?"

    Measured: Up to 1 month after the 12-week program

  23. Outdoor Professional Dementia Knowledge

    Dementia Knowledge Assessment

    Measured: Up to 1 month before and after the dementia training

  24. Outdoor Professional strategies for tailoring activities

    Strategies for Tailoring Activities quiz

    Measured: Up to 1 month before and after the strategy training

  25. Outdoor Professional brief phone interview

    15-minute brief phone interview post

    Measured: Up to 2 weeks after the 12 week program

  26. Sustained Behavior Change for People Living with Memory Challenges

    3 Questions asked via phone

    1. Are you still doing the activities?
    2. (If yes) Do you plan to continue doing the activities? (If no) Why not? Do plan to do them in the future?
    3. Have you added any new activities?

    Measured: 1 month after the 12 week program

  27. Cognitive function

    T-MoCa

    Measured: Up to 1 month before and after 12 week program

  28. Usability

    Holden's Simplified Systems Usability Scale (SSUS)

    Measured: up to 2 weeks after baseline testing with the ActiGraph LEAP and CenterePointe App software

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 May 2024
  2. Study start17 Jul 2024
  3. Primary completion30 Nov 2026 (estimated)
  4. Study completion30 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06403345
Sponsor's protocol ID
22206
Acronym
GAP
Status last verified
Jul 2026
First submitted
26 Apr 2024
Last updated
15 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Lassell R, Metaxas A, Wang K, Hantgan S, Gottipati P, Zwerling S, Pena T, Pollak C, Gitlin L, Jariwala S. Applying the Human-Centered Innovation Biodesign Framework to the Development and Piloting of a Program to Mitigate Risk for Cognitive Decline Among Historically Underrepresented Individuals: Case Study. JMIR Form Res. 2025 Oct 15;9:e64930. doi: 10.2196/64930.

    PubMed 41092385

Questions about this trial

What is this clinical trial studying?

A study testing Green Activity Program in people with Mild Cognitive Impairment and Alzheimer Disease, run by Indiana University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 15 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Rebecca Lassell, PhD (812-855-2395, blassell@iu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility intervention completion rate (time frame: Through study completion). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06403345, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in